http://www.raredr.com/news/amyloidosis-takeda-oncology
Amyloidosis Studies at Takeda Oncology

James Radke, PhD



In a recent interview with Rare Disease Report, Dixie Esseltine, MD, FRCPC, of Takeda Oncology explains the studies underway to test bortezomib (Velcade) and ixazomib in patients with amyloidosis.
Printer Printing...
$content$